Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B DREYER

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
American Journal of Human Genetics|June 13, 2001
A common ancestral origin of the frequent and widespread 2299delG USH2A mutationB Dreyer, L Tranebjaerg, V Brox, et al.
Biochemistry|August 7, 1992
Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assaysG B Dreyer, D M Lambert, T D Meek, et al.
Biochemistry|November 6, 1992
Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 proteaseT A Tomaszek, M L Moore, J E Strickler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2020
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicineR Casolino, C Braconi, G Malleo, et al.
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic proteaseT D Meek, B D Dayton, B W Metcalf, et al.
The British Journal of Surgery|May 7, 2026
Clinical and molecular landscape of surgically resected early onset pancreatic cancerStephan B Dreyer, Adam Bryce, Fieke Froeling, et al.
Nature|January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesT D Meek, D M Lambert, G B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitorsG B Dreyer, B W Metcalf, T A Tomaszek, et al.
Biochemical and Biophysical Research Communications|March 15, 1989
Peptide substrates and inhibitors of the HIV-1 proteaseM L Moore, W M Bryan, S A Fakhoury, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Human Genetics|June 13, 2001
A common ancestral origin of the frequent and widespread 2299delG USH2A mutationB Dreyer, L Tranebjaerg, V Brox, et al.
Biochemistry|August 7, 1992
Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assaysG B Dreyer, D M Lambert, T D Meek, et al.
Biochemistry|November 6, 1992
Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 proteaseT A Tomaszek, M L Moore, J E Strickler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2020
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicineR Casolino, C Braconi, G Malleo, et al.
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic proteaseT D Meek, B D Dayton, B W Metcalf, et al.
The British Journal of Surgery|May 7, 2026
Clinical and molecular landscape of surgically resected early onset pancreatic cancerStephan B Dreyer, Adam Bryce, Fieke Froeling, et al.
Nature|January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesT D Meek, D M Lambert, G B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitorsG B Dreyer, B W Metcalf, T A Tomaszek, et al.
Biochemical and Biophysical Research Communications|March 15, 1989
Peptide substrates and inhibitors of the HIV-1 proteaseM L Moore, W M Bryan, S A Fakhoury, et al.
Pageof 10